ALKBH5 and pancreatic neuroendocrine tumor: Studies indicate ALKBH5’s abnormal expression in various cancers, including gastric cancer, t(8;21)AML, pancreatic neuroendocrine tumors, and glioblastoma, linking it to tumorigenesis and progression (Table 1).